AI assistant
CONMED Corp — Director's Dealing 2016
Jun 3, 2016
31971_dirs_2016-06-03_95e70cfd-d23d-4ed2-8ace-80f475f3553e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-06-01
Reporting Person: Berge Terence M (VP Corp. Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-01 | Common Stock | M | 600 | — | Acquired | 14038 | Direct |
| 2016-06-01 | Common Stock | F | 222 | $41.06 | Disposed | 13816 | Direct |
| 2016-06-01 | Common Stock | M | 800 | — | Acquired | 14616 | Direct |
| 2016-06-01 | Common Stock | F | 296 | $41.06 | Disposed | 14320 | Direct |
| 2016-06-01 | Common Stock | M | 800 | — | Acquired | 15120 | Direct |
| 2016-06-01 | Common Stock | F | 296 | $41.06 | Disposed | 14824 | Direct |
| 2016-06-01 | Common Stock | M | 800 | — | Acquired | 15624 | Direct |
| 2016-06-01 | Common Stock | F | 296 | $41.06 | Disposed | 15328 | Direct |
| 2016-06-01 | Common Stock | M | 520 | — | Acquired | 15848 | Direct |
| 2016-06-01 | Common Stock | F | 193 | $41.06 | Disposed | 15655 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-01 | Rsus (restricted Stock Units) | $0 | M | 600 | Disposed | 2020-06-01 | Common Stock (600) | Direct |
| 2016-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2021-06-01 | Common Stock (800) | Direct |
| 2016-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2022-06-01 | Common Stock (800) | Direct |
| 2016-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2023-06-01 | Common Stock (800) | Direct |
| 2016-06-01 | Rsus (restricted Stock Units) | $0 | M | 520 | Disposed | 2024-06-01 | Common Stock (520) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.